Archive for the 'Biotech' Category

Biotech is in Play – OSI Pharmaceuiticals

The 50% premium being paid for OSIP by Astellas, which is roughly $52/share, was actually rejected by the board. The market is pricing the stock at $56, and I think the stock climbs another $10 from here. There will be another bidder. The M&A attention is bullish for the sector. There are some good plays [...]

Invitation to Join New LinkedIn Group

With all of the clutter and insanity due to groups turning into recruiting grounds and advertising forums for esoteric and mindless products, I was compelled to launch my own LinkedIn Group which is being emphatically embraced by the systematic and discretionary proprietary trading universe, to my delight. I know many of you are Prop. Traders, [...]